Fas gene dosage tunes the extent of lymphoproliferation and T cell differentiation in lupus
Clinical Immunology · 2024
DOI: 10.1016/j.clim.2023.109874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2024. Verfasst von Ritu Bohat und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, United States of America. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Aligning Science Across Parkinson's.
Abstract (Originalsprache)
Sle1 and Faslpr are two lupus susceptibility loci that lead to manifestations of systemic lupus erythematosus. To evaluate the dosage effects of Faslpr in determining cellular and serological phenotypes associated with lupus, we developed a new C57BL/6 (B6) congenic lupus strain, B6.Sle1/Sle1.Faslpr/+ (Sle1homo.lprhet) and compared it with B6.Faslpr/lpr (lprhomo), B6.Sle1/Sle1 (Sle1homo), and B6.Sle1/Sle1.Faslpr/lpr (Sle1homo.lprhomo) strains. Whereas Sle1homo.lprhomo mice exhibited profound lymphoproliferation and early mortality, Sle1homo.lprhet mice had a lifespan comparable to B6 mice, with no evidence of splenomegaly or lymphadenopathy. Compared to B6 monogenic lupus strains, Sle1homo.lprhet mice exhibited significantly elevated serum ANA antibodies and increased proteinuria. Additionally, Sle1homo.lprhet T cells had an increased propensity to differentiate into Th1 cells. Gene dose effects of Faslpr were noted in upregulating serum IL-1⍺, IL-2, and IL-27. Taken together, Sle1homo.lprhet strain is a new C57BL/6-based model of lupus, ideal for genetic studies, autoantibody repertoire investigation, and for exploring Th1 effector cell skewing without early-age lymphoproliferative autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, United States of America.
- Department of Biomedical Engineering, University of Houston, Houston, TX 77204, United States of America.
- Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America; UTHealth Graduate School of Biomedical Sciences, The University of…
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, United States of America.
- Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America; Department of Systems Biology, The University of Texas MD Anderson…
- Department of Cellular & Molecular Physiology, Penn State College of Medicine, Hershey, PA 17033, United States of America.
Förderung
- NIDDK NIH HHS
- Aligning Science Across Parkinson's
Zitieren
APA
Bohat, R., Liang, X., Chen, Y., Xu, C., Zheng, N., Guerrero, A., Hou, J., Jaffery, R., Egan, N. A., Li, Y., Tang, Y., Unsal, E., Robles, A., Chen, S., Major, A. M., Elldakli, H., Chung, S. H., Liang, H., Hicks, M. J., …, & Peng, W. (2024). Fas gene dosage tunes the extent of lymphoproliferation and T cell differentiation in lupus. Clinical Immunology. https://doi.org/10.1016/j.clim.2023.109874
Vancouver
Bohat R, Liang X, Chen Y, Xu C, Zheng N, Guerrero A, et al. Fas gene dosage tunes the extent of lymphoproliferation and T cell differentiation in lupus. Clinical Immunology. 2024. doi:10.1016/j.clim.2023.109874
BibTeX
@article{Bohat2024,
author = {Bohat, Ritu and Liang, Xiaofang and Chen, Yanping and Xu, Chunyu and Zheng, Ningbo and Guerrero, Ashley and Hou, Jiakai and Jaffery, Roshni and Egan, Nicholas A and Li, Yaxi and Tang, Yitao and Unsal, Esra and Robles, Adolfo and Chen, Si and Major, Angela M and Elldakli, Hadil and Chung, Sang-Hyuk and Liang, Han and Hicks, M John and Du, Yong and Lin, Jamie S and Chen, Xiqun and Mohan, Chandra and Peng, Weiyi},
title = {Fas gene dosage tunes the extent of lymphoproliferation and T cell differentiation in lupus},
journal = {Clinical Immunology},
year = {2024},
doi = {10.1016/j.clim.2023.109874}
}
EUVIMED